These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26440400)

  • 21. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not?
    Warkentin TE; Greinacher A
    Chest; 2007 Oct; 132(4):1108-10. PubMed ID: 17934108
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombelastography in a patient with heparin-induced thrombocytopenia treated with argatroban.
    Zayac EA; Pivalizza EG; Levine RL
    Anesth Analg; 2008 Jan; 106(1):351-2. PubMed ID: 18165611
    [No Abstract]   [Full Text] [Related]  

  • 23. [Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
    Steinfeldt T; Rolfes C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):304-10; quiz 312. PubMed ID: 18409125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin-induced thrombocytopenia.
    Borkowski DA; Force RW
    Am J Health Syst Pharm; 1995 Nov; 52(22):2528, 2535-6. PubMed ID: 8590236
    [No Abstract]   [Full Text] [Related]  

  • 25. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
    Lobo B; Finch C; Howard A; Minhas S
    Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The serological profile of early-onset and persisting post-cardiac surgery thrombocytopenia complicated by "true" heparin-induced thrombocytopenia.
    Warkentin TE; Moore JC; Vogel S; Sheppard JA; Warkentin NI; Eikelboom JW
    Thromb Haemost; 2012 May; 107(5):998-1000. PubMed ID: 22371139
    [No Abstract]   [Full Text] [Related]  

  • 27. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fondaparinux in heparin-induced thrombocytopenia.
    Gevaert A; Smets H; Vercauteren R
    Acta Cardiol; 2013 Oct; 68(5):517-20. PubMed ID: 24283115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin induced thrombocytopenia diagnosis in cardiac surgery: is there a role for thromboelastography?
    Kouerinis IA; Kourtesis A; El-Ali M; Sergentanis T; Plagou A; Argiriou M; Theakos N; Giannakopoulou A
    Interact Cardiovasc Thorac Surg; 2008 Aug; 7(4):560-3. PubMed ID: 18056152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin induced thrombocytopenia after low molecular weight heparin treatment: a case report.
    Illuminati G; Caliò FG; Bertagni A; Forte A; Gallinaro L; Montesano G; Ciulli A
    Riv Eur Sci Med Farmacol; 1996; 18(5-6):225-8. PubMed ID: 9177626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fondaparinux-associated heparin-induced thrombocytopenia.
    Bhatt VR; Aryal MR; Shrestha R; Armitage JO
    Eur J Haematol; 2013 Nov; 91(5):437-41. PubMed ID: 23905719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fondaparinux monitoring in a patient with heparin-induced thrombocytopenia on hemodialysis.
    Kušić J; Kulić A; Djurković V; Marković R; Milačić V; Surić-Lambić L; Peković G
    Srp Arh Celok Lek; 2016; 144(11-12):654-6. PubMed ID: 29659233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic fondaparinux use in a hemodialysis patient with heparin-induced thrombocytopenia type II and extracorporeal circuit thrombosis-a case report and review of the literature.
    Brown P; Jay R; Fox A; Oliver M
    Hemodial Int; 2013 Jul; 17(3):444-9. PubMed ID: 23216938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low molecular weight heparins--a safer option than unfractionated heparin?
    McKay GA; Paterson KR
    Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):256-76. PubMed ID: 11770172
    [No Abstract]   [Full Text] [Related]  

  • 35. Skin necrosis is a clinical manifestation of low-molecular weight heparin-induced thrombocytopenia.
    Fontana P; Bodmer A; Gruel Y; Boehlen F; Janer V; Kaya G; Righini M
    Thromb Haemost; 2004 Jan; 91(1):196-7. PubMed ID: 14691586
    [No Abstract]   [Full Text] [Related]  

  • 36. [Clinical significance and problems of treatment of patients with heparin-induced thrombocytopenia].
    Barkagan ZS
    Ter Arkh; 1999; 71(7):72-6. PubMed ID: 10481872
    [No Abstract]   [Full Text] [Related]  

  • 37. Heparin, low molecular weight heparin, and heparin-induced thrombocytopenia in the ICU.
    Warkentin TE; Cook DJ
    Crit Care Clin; 2005 Jul; 21(3):513-29. PubMed ID: 15992671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heparin-induced thrombocytopenia: a complication of thromboprophylaxis.
    Kejariwal D
    J Bone Joint Surg Br; 2006 Mar; 88(3):392-3. PubMed ID: 16498019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitation of serotonin from platelets using enzyme-immunoassay in the presence of serum from HIT-patients.
    Harenberg J; Koch S; Giese C; Wang LC; Hoffmann U; Huhle G
    Thromb Haemost; 2000 May; 83(5):795-6. PubMed ID: 10823286
    [No Abstract]   [Full Text] [Related]  

  • 40. Heparins, low-molecular-weight heparins, and pentasaccharides.
    Dinwoodey DL; Ansell JE
    Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.